Back to Results
First PageMeta Content
Medicine / CD8+ cell / Lymphocyte / White blood cell / Interferon-gamma / T helper cell / Oncolytic virus / Tumor antigen / T cells / Biology / Immune system


Characterization of tumor-infiltrating lymphocytes following intratumoral administration of ONCOS-102 for refractory solid tumor cancer patients Pesonen S1, Hemminki A2, von Euler M1, Vuolanto A1, Backman C1, Hakonen T1,
Add to Reading List

Document Date: 2014-06-19 02:40:06

Open Document

File Size: 879,84 KB

Share Result on Facebook

City

Frankfurt / Helsinki / /

Company

AEs / Joensuu T2 1Oncos Therapeutics Ltd / Science Ltd / CONTACT Oncos Therapeutics Ltd. / /

Country

Finland / /

/

Event

FDA Phase / /

Facility

University of Helsinki / Haartman Institute / University Central Hospital / Cancer Center / Helsinki University Central Hospital / /

MedicalCondition

tumor / patient’s unique cancer / cancer / tumors / refractory solid tumor cancer / chills / pain / fatigue / malignant pleural mesothelioma / Last-line solid tumor / T cell DC DC DC Tumor / /

MedicalTreatment

vaccination / /

OperatingSystem

Mac OS X / /

Organization

University of Helsinki / Helsinki / Center for Science Ltd / University Central Hospital / HUSLAB / 3Docrates Cancer Center / Helsinki University Central Hospital / Haartman Institute / /

/

Product

CD8 / /

ProgrammingLanguage

DC / /

Technology

Gene Therapy / DNA Chip / antibodies / gene expression / /

URL

www.oncos.com / /

SocialTag